A shekara ta 2019, masana sun bayar da rahoton amfani na farko a mutane da haɗin Dasatinib da Quercetin a marasa lafiya 14 da ke da cutar huhu marar sanadi (IPF). Bayan makonni uku na shan magani a lokuta‑lokuta, mahalarta sun samu ƙaruwa a nisan tafiyar minti 6, gudun tafiya, da lokacin tashi daga kujerar, amma aikin huhu bai canza ba. Gwajin ya kuma samu rahoton wani mummunan abin da ya faru da kuma yawan korafe‑korafen numfashi, fata da na ciki. Wannan bincike ne na buɗe‑ra’ayi, ba tare da rukunin ƙarya ba, inda aka haɗa maganin da kulawar likita, ba tsarin kari na ƙwayoyi ba. Ga abin da gwajin ya gwada, abin da ya gano, da yadda za a fassara sakamakon da hankali.
This page is available in